WASHINGTON — The maker of the only U.S. drug intended to prevent premature births is making a last-ditch effort this week to keep its medication on the market, even as health regulators insist that it doesn’t work. “Makena and its associated generics represent the only treatment currently available to obstetrician-gynecologists to help prevent this condition.” But the FDA says existing …
Detroit: According to a new study, SARS-CoV-2, the virus that causes COVID-19, may cause fetal inflammation even in the absence of placental infection. The study reported that COVID-19 infection during pregnancy may cause inflammatory immune responses in the foetus, even if the virus does not infect the placenta. The study, conducted by Nardhy Gomez-Lopez, PhD, associate professor of the WSU …
